EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

The New Frontier of JAK Inhibitors: Significant Therapeutic Response to Tofacitinib in a Patient With Granulomatous Reaction to Filler in the Buttocks

Parvin Mansouri, Susan Farshi iD

Journal of Cosmetic Dermatology · 2024-12 · 23 (12) · 3924-3926

DOI: 10.1111/jocd.16578 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 15.10.2024. Verfasst von Parvin Mansouri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Piperidines, Pyrimidines, Janus Kinase Inhibitors, Dermal Fillers. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recent research has demonstrated that Janus Kinase (JAK) inhibitors can be effective in treating refractory granulomatous diseases. Case Presentation We report the case of a 50‐year‐old woman who developed a granulomatous reaction following a filler injection in her buttocks. Management The patient was treated with tofacitinib, and after 1 year of therapy, the stiffness and swelling resolved without any side effects.

Conclusion

Tofacitinib appears to be a viable option for the treatment of granulomatous reactions to fillers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PiperidinesPyrimidinesJanus Kinase InhibitorsDermal FillersHumansFemaleMiddle AgedButtocksPyrrolesGranulomaTreatment OutcomeCosmetic Techniques

Stichwörter der Autor:innen

JAK inhibitorsgranulomatofacitinib

Substanzen

tofacitinibPiperidinesPyrimidinesJanus Kinase InhibitorsDermal FillersPyrroles

Autor:innen und Institutionen

  • Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Susan Farshi

Zitieren

APA

Mansouri, P., & Farshi, S. (2024). The New Frontier of JAK Inhibitors: Significant Therapeutic Response to Tofacitinib in a Patient With Granulomatous Reaction to Filler in the Buttocks. Journal of Cosmetic Dermatology, 23(12), 3924-3926. https://doi.org/10.1111/jocd.16578

Vancouver

Mansouri P, Farshi S. The New Frontier of JAK Inhibitors: Significant Therapeutic Response to Tofacitinib in a Patient With Granulomatous Reaction to Filler in the Buttocks. Journal of Cosmetic Dermatology. 2024;23(12):3924-3926. doi:10.1111/jocd.16578

BibTeX
@article{Mansouri2024,
  author = {Mansouri, Parvin and Farshi, Susan},
  title = {The New Frontier of JAK Inhibitors: Significant Therapeutic Response to Tofacitinib in a Patient With Granulomatous Reaction to Filler in the Buttocks},
  journal = {Journal of Cosmetic Dermatology},
  year = {2024},
  volume = {23},
  number = {12},
  pages = {3924--3926},
  doi = {10.1111/jocd.16578}
}
Kostenlos starten →